Efficacy and Safety Evaluation of AN2690 Topical Solution to Treat Onychomycosis of the Toenail

Completed · Phase 3

Conditions studied: Onychomycosis of Toenails

In brief

The purpose of this study is to determine whether AN2690 topical solution is a safe and effective treatment for onychomycosis of the toenail.

Key facts

Study ID

NCT01270971

Run by

Pfizer

People needed

594

Starts

2010-12-01

Expected to finish

2013-01-08

Last updated by the study team

2019-02-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Clinical diagnosis of distal subungual onychomycosis affecting at least one great toenail
• KOH positive at screening
• Willingness not to use any other products including nail polish applied to the toenails during the study
• Women of childbearing potential who are currently sexually active must agree to use contraception for the entire study period

You may not qualify if…

• Concurrent or recent use of certain topical or systemic medications without a sufficient washout period
• History of any significant chronic fungal disease other than onychomycosis
• Significant confounding conditions as assessed by study doctor
• Participated in any other trial of an investigational drug or device within 30 days or participation in a research study concurrent with this study
• Pregnancy or lactation

Where it is running

• Investigational Site — Tucson, Arizona, United States
• Investigational Site — Hot Springs, Arkansas, United States
• Investigational Site — Burbank, California, United States
• Investigational Site — Los Angeles, California, United States
• Investigational Site — San Francisco, California, United States
• Investigational Site — Denver, Colorado, United States
• Investigational Site — Orange Park, Florida, United States
• Investigational Site — Boise, Idaho, United States
• Investigational Site — Evansville, Indiana, United States
• Investigational Site — Overland Park, Kansas, United States
• Investigational Site — Baltimore, Maryland, United States
• Investigational Site — Fridley, Minnesota, United States
• Investigational Site — Omaha, Nebraska, United States
• Investigational Site — New York, New York, United States
• Investigational Site — New York, New York, United States
• Investigational Site — Rochester, New York, United States
• Investigational Site — Winston-Salem, North Carolina, United States
• Investigational Site — Cincinnati, Ohio, United States
• Investigational Site — South Euclid, Ohio, United States
• Investigational Site — Portland, Oregon, United States
• Investigational Site — Providence, Rhode Island, United States
• Investigational Site — Germantown, Tennessee, United States
• Investigational Site — Austin, Texas, United States
• Investigational Site — College Station, Texas, United States
• Investigational Site — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.